Education
About Us
Working with TipRanks
Follow Us
RFG - ETF AI Analysis
Top Page
Invesco S&P Midcap 400 Pure Growth ETF (RFG)
Rating:70Neutral
Price Target:―
Positive Factors
Strong Top Holdings
Several of the largest positions, such as Comfort Systems and Hims & Hers Health, have delivered strong year-to-date gains, supporting the ETF's overall performance.
Sector Diversification
The ETF is spread across multiple sectors, including Industrials, Health Care, and Technology, reducing reliance on any single industry.
Reasonable Expense Ratio
With an expense ratio of 0.35%, the fund offers relatively low costs compared to actively managed alternatives.
Negative Factors
High U.S. Concentration
The ETF is almost entirely focused on U.S. companies, limiting exposure to international markets and diversification.
Underperforming Holdings
Some holdings, such as Aaon and Valaris, have shown weak year-to-date performance, which could drag on the fund's returns.
Small Asset Base
With relatively low assets under management, the ETF may face challenges in attracting liquidity and scaling further.
RFG vs. SPDR S&P 500 ETF (SPY)
AUM289.12M
RegionNorth America
Expense Ratio0.35%
Beta1.09
IssuerInvesco
Inception DateMar 01, 2006
Dividend Yield0.42%
Asset ClassEquity
Index TrackedS&P Mid Cap 400 Pure Growth
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume6,383
30 Day Avg. Volume8,935
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
61.97Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering97
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
RFG Summary
The Invesco S&P Midcap 400 Pure Growth ETF (RFG) is an investment fund that focuses on mid-sized companies in the U.S. with strong growth potential. It follows the S&P Mid Cap 400 Pure Growth Index, which includes businesses showing rapid earnings and sales growth. Some of its top holdings include Comfort Systems, a company specializing in heating and cooling solutions, and Roivant Sciences, a healthcare innovator. Investors might consider RFG for its potential to deliver higher returns than large-cap stocks while offering more stability than small-cap stocks. However, it’s important to note that this ETF is heavily dependent on mid-cap companies, which can be more volatile than larger, established firms.
How much will it cost me?The Invesco S&P Midcap 400 Pure Growth ETF (RFG) has an expense ratio of 0.35%, which means you’ll pay $3.50 per year for every $1,000 invested. This cost is slightly higher than average because the fund is actively managed to focus on mid-cap growth stocks, requiring more research and strategy compared to passively managed ETFs. It’s designed for investors seeking targeted exposure to companies with strong growth potential.
What would affect this ETF?The Invesco S&P Midcap 400 Pure Growth ETF (RFG) could benefit from economic growth and innovation within sectors like Industrials, Health Care, and Technology, which make up a significant portion of its holdings. However, it may face challenges if interest rates rise, as growth stocks often become less attractive in such environments, or if economic uncertainty impacts mid-cap companies more heavily than larger firms. Regulatory changes or sector-specific disruptions could also influence the performance of its top holdings.
RFG Top 10 Holdings
The Invesco S&P Midcap 400 Pure Growth ETF (RFG) leans heavily into industrials, healthcare, and technology, with these sectors driving much of its performance. Comfort Systems and Carpenter Technology are rising stars, benefiting from strong demand and effective pricing strategies, while Globus Medical adds steady momentum with strategic growth initiatives. On the flip side, Hims & Hers Health is lagging, weighed down by bearish technical trends and valuation concerns. With its U.S.-focused portfolio, the fund captures mid-cap growth opportunities but remains vulnerable to sector-specific headwinds.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Comfort Systems | 4.08% | $11.98M | $35.44B | 102.08% | 75 Outperform | |
| Roivant Sciences | 3.67% | $10.77M | $14.73B | 75.33% | 61 Neutral | |
| Carpenter Technology | 3.01% | $8.84M | $15.68B | 61.52% | 74 Outperform | |
| Valaris | 2.43% | $7.13M | $4.15B | 32.83% | 77 Outperform | |
| Hims & Hers Health | 2.05% | $6.03M | $9.11B | 26.64% | 67 Neutral | |
| Globus Medical | 1.88% | $5.53M | $11.94B | 6.80% | 82 Outperform | |
| ATI | 1.82% | $5.34M | $13.64B | 71.68% | 74 Outperform | |
| MasTec | 1.78% | $5.22M | $17.29B | 55.11% | 69 Neutral | |
| Exelixis | 1.66% | $4.88M | $11.90B | 23.11% | 76 Outperform | |
| Medpace Holdings | 1.63% | $4.78M | $15.35B | 59.15% | 79 Outperform |
RFG Technical Analysis
Positive
―
Price Trends
51.30
Positive
50.88
Positive
48.42
Positive
Market Momentum
0.35
Negative
60.45
Neutral
87.46
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For RFG, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 51.57, equal to the 50-day MA of 51.30, and equal to the 200-day MA of 48.42, indicating a bullish trend. The MACD of 0.35 indicates Negative momentum. The RSI at 60.45 is Neutral, neither overbought nor oversold. The STOCH value of 87.46 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for RFG.
RFG Peer Comparison
Comparison Results
Performance Comparison
RFG
Invesco S&P Midcap 400 Pure Growth ETF
52.91
0.68
1.30%
FNY
First Trust Mid Cap Growth AlphaDEX Fund
―
―
―
NUMG
Nuveen ESG Mid-Cap Growth ETF
―
―
―
TMFM
Motley Fool Mid-Cap Growth ETF
―
―
―
GLRY
Inspire Faithward Mid Cap Momentum ESG ETF
―
―
―
FRTY
Alger Mid Cap 40 ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents